Wednesday

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noreferrer noopener" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div> 
<p class="has-drop-cap">Health insurance giant Humana Inc. (NYSE: HUM) saw its stock price plummet by more than 5% on Wednesday after the company <a href="https://humana.gcs-web.com/financial-information/quarterly-results" target="_blank" aria-label="withdrew (opens in a new tab)" rel="noreferrer noopener nofollow" class="deco-link">withdrew</a> its financial guidance for the year 2025. The decision to pull the guidance was attributed to uncertainties surrounding federal rate adjustments for Humana’s core Medicare Advantage business, which plays a crucial role in the company’s operations and overall performance.</p> 
<h3 id="humana-beats-eps-expectations-for-q1">Humana Beats EPS Expectations for Q1</h3> 
<p>Despite the setback, Humana beat earnings expectations for the first quarter of 2024, reporting an adjusted earnings per share (<a href="https://tokenist.com/investing/how-to-value-a-stock/" rel="dofollow" class="deco-link">EPS</a>) of $7.23, surpassing the FactSet consensus estimate of $6.12. However, the company’s net income for the quarter declined to $1.01 billion from $1.61 billion a year ago, indicating a decrease in profitability compared to the previous year.</p> 
<p>Despite earlier warnings that higher medical costs could negatively impact future results, Humana has successfully kept its medical costs in line with projections. The company’s ability to manage these costs effectively has been a positive factor amidst the uncertainty surrounding the Medicare Advantage business.</p> 
<div class="cta-referral"> 
 <img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async"> 
 <div class="cta-referral__text"> 
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noreferrer noopener nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p> 
 </div> 
</div> 
<h3 id="humana-stock-down-36-over-the-past-year">Humana Stock Down 36%+ Over the Past Year</h3> 
<p>Looking ahead, Humana remains optimistic about the long-term performance of its Medicare business but has cautioned investors about potential challenges and the need for a recovery period to stabilize margins at 3% or higher. <br><br>The company’s leadership team is actively working on strategies to navigate the evolving healthcare landscape and maintain a strong market position.</p> 
<p>At the time of writing, Humana’s stock price stood at $311.28, reflecting the recent 5.09% decline. Over the past year, the company’s stock has underperformed significantly, with a decline of 36.10% compared to a 22.50% increase in the <a href="https://tokenist.com/the-bull-and-bear-case-for-spx-in-2024/" rel="dofollow" class="deco-link">S&amp;P 500</a>. <br><br>Despite the recent volatility, Humana has a <a href="https://tokenist.com/investing/what-is-beta-in-stocks/" class="deco-link">beta</a> of approximately 0.74, indicating lower volatility compared to the broader market, and a <a href="https://tokenist.com/investing/p-e-ratio/" class="deco-link">Price/Earnings (TTM) ratio</a> of around 16.40, suggesting a relatively reasonable valuation in the context of the healthcare sector.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe> 
<p><strong><em>Do you think the market is reacting appropriately to the news? Let us know in the comments below.</em></strong></p> 
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p> 
<h3 id="br"><br></h3> 
<p>The post <a rel="nofollow" href="https://tokenist.com/humana-stock-drops-over-5-as-firm-pulls-guidance/">Humana Stock Drops Over 5% as Firm Pulls Guidance</a> appeared first on <a rel="nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Humana Stock Drops Over 5% as Firm Pulls Guidance

Table of Contents

Tokenist

Other articles published on Apr 24, 2024

Ethereum Reclaims NFT Market Crown – Could It Be The NFT Bull Run Loading?

Stacks Nakamoto Upgrade Begins Rollout: The Leading Layer 2 Will Soon Be Faster and More Secure

Tesla Maintains Bitcoin Holdings, Reveals Plans for Robotaxi Service

BONK Meme Coin Surges in Crypto Market

Tesla Stock Up 10%+ as Musk Promises Cheaper EVs and Robots

Polygon’s MATIC Shows Buy Signals Across Key Technical Indicators: Here’s What to Watch

Join our free newsletter for daily crypto updates!